Description
There is a long-acting fluphenazine decanoate formulation used primarily as maintenance therapy for chronic schizophrenia and related psychotic disorders in patients who do not tolerate oral formulations or in patients where medication compliance is a concern of the provider. It is a first-generation antipsychotic.
